{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:31:26Z","timestamp":1794738686016,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.antiviral.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T13:35:26Z","timestamp":1539264926000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":369,"special_numbering":"C","title":["In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit"],"prefix":"10.1016","volume":"160","author":[{"given":"Takeshi","family":"Noshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Kushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6625-1679","authenticated-orcid":false,"given":"Akihiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Okamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.10.008_bib1","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/cb400400j","article-title":"Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors","volume":"8","author":"Bauman","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2018.10.008_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/AAC.04623-14","article-title":"Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit","volume":"59","author":"Byrn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0042-6822(69)90354-7","article-title":"Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity","volume":"39","author":"Choppin","year":"1969","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.10.008_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/095632029600700609","article-title":"Identification of N-hydroxamic acid and N-hydroxy-imide compounds that inhibit the influenza virus polymerase","volume":"7","author":"Cianci","year":"1996","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1128\/JVI.79.13.8669-8674.2005","article-title":"In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex","volume":"79","author":"Deng","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature07745","article-title":"The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit","volume":"458","author":"Dias","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.93.18.9742","article-title":"Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules","volume":"93","author":"Farnet","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2018.10.008_bib8","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.76.18.8989-9001.2002","article-title":"A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs","volume":"76","author":"Fodor","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.008_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-Influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.008_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059892","article-title":"High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7","volume":"8","author":"Hamamoto","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2018.10.008_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.10.008_bib12","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1099\/0022-1317-81-12-2843","article-title":"Unidirectional RNA polymerase I \u2013 polymerase II transcription system for the generation of influenza A virus from eight plasmids","volume":"81","author":"Hoffmann","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.10.008_bib13","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1021\/jm400645w","article-title":"Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S\/GSK1349572) and (S\/GSK1265744)","volume":"56","author":"Johns","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.10.008_bib14","article-title":"Identification of the I38T PA substitution as a resistance marker for next-generation influenza virus endonuclease inhibitors","volume":"9","author":"Jones","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2018.10.008_bib15","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1128\/AAC.00888-16","article-title":"A novel endonuclease inhibitor exhibits broad-spectrum anti-influenza virus activity in vitro","volume":"60","author":"Jones","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.008_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2010.12.014","article-title":"Strand-specific real-time RT-PCR for distinguishing influenza vRNA , cRNA , and mRNA","volume":"173","author":"Kawakami","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2018.10.008_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0076-6879(01)42566-3","article-title":"Influenza virus endoribonuclease","volume":"342","author":"Klumpp","year":"2001","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.antiviral.2018.10.008_bib18","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.bmcl.2016.08.038","article-title":"Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza cap-dependent endonuclease","volume":"26","author":"Miyagawa","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2018.10.008_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.10.008_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/nar\/gkx1210","article-title":"Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors","volume":"46","author":"Pflug","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.10.008_bib21","series-title":"Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by Vaccination in the United States","author":"Rolfes","year":"2016"},{"key":"10.1016\/j.antiviral.2018.10.008_bib22","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.ccr.2012.07.006","article-title":"Viral enzymes containing magnesium: metal binding as a successful strategy in drug design","volume":"256","author":"Rogolino","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.antiviral.2018.10.008_bib23","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.10.008_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkp274","article-title":"Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells","volume":"64","author":"Smee","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2018.10.008_bib25","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1128\/JVI.00832-13","article-title":"Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease","volume":"87","author":"Stevaert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.10.008_bib26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","article-title":"Influenza virus-host interactome screen as a platform for antiviral drug development","volume":"16","author":"Watanabe","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2018.10.008_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nature07720","article-title":"Crystal structure of an avian influenza polymerase PA N reveals an endonuclease active site","volume":"458","author":"Yuan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.10.008_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3201\/eid2308.170640","article-title":"Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017","volume":"23","author":"Zhou","year":"2017","journal-title":"Emerg. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:28:49Z","timestamp":1759062529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"alternative-id":["S0166354218303632"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.10.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}